AN ANTHOLOGY OF DIABETES

Neha Kamalta, Anil Kumar, Hemraj Vashist, Ram Babu Sharma

Abstract


Diabetes mellitus is a group of metabolic disorders characterized by hyperglycemia; associated with abnormalities in carbohydrate, fat and protein metabolism; and resulting in chronic complications including micro vascular and neuropathic. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger.the present work is a collection os different aspect of the disease.

 


Keywords


Diabetes mellitus, metabolic disorders, hyperglycemia

Full Text:

1-6

References


American diabetes association, 1998. Economic consequences of diabetes mellitus in the united states in 1997. Diabetes care, 21:296-309.

Anonymous. 2004. Diagnosis and classification of diabetes mellitus – position statement.

Ashcroft, f.m. and s.j.h. ashcroft, 1992. Insulin, molecular biology to pathology. Oxford university press. Pp 266-284.

Banting, f.g., c.h. best, j.b. collip, w.r. campbell, and a.a. fletcher, 1922. Pancreatic extracts in the treatment of diabetes mellitus. Preliminary report. Canadian medical association journal, 145(10):1281-1286.

Barcelo a, aedo c, rajpathak s and robles s. 2003. The cost of diabetes in latin america and the caribbean. Bulletin of the world health organization, 81(1):19-27.

Belinda r. 2004. Gale encyclopaedia of alternative medicine. Pp 2603-2605.

Cahill gf jr and boston md.1971. Physiology of insulin in man. Diabetes, 20(12):785-799.

Collins fm. 2002. Current treatment approaches to type 2 diabetes mellitus successes and shortcomings. American journal of managed care, 8(16 suppl):s460-s471.

Consoli a. 1992. Role of liver in pathophysiology of niddm. Diabetes care, 15(3):430-41.

Curtis lt. 2007. New technologies and therapies in the management of diabetes. American journal of managed care, 13(2 suppl): s47-s54

Defronzo ra. 2010. Current issues in the treatment of type 2 diabetes. Overview of newer agents: where treatment is going. Am j med 123(3 suppl):s38-48. Doi: 10.1016

. Gray a, mcguire a and fenn p. 1995. The cost of insulindependent diabetes mellitus (iddm) in england and wales. Diabetic med, 12(12):1068-1076

Halter jb, ward wk, porte d, jr., best jd and pfeifer ma. 1985. Glucose regulation in non-insulindependent diabetes mellitus. Interaction between pancreatic islets and the liver. Am j med 79(2b):6-12.

. Hart wm, espinosa c and rovira j. 1997. Cost of unknown diabetes mellitus in spain. Med clin (barcelona), 109:289- 293.

. Himsworth hp. 1936. Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types. Lancet, 227(5864):127-130.

Hoppener jw and lips cj. 2006. Role of islet amyloid in type 2 diabetes mellitus. Int j biochem cell biol, 38(5- 6):726-36.

Inzucchi se. 2002. Oral antihyperglycemic therapy for type 2 diabetes: scientific review. Jama, 287(3):360-372.

John c. 1998. Treatment of diabetes mellitus with herbs. Annual review of pharmacology, 13: 35-43.

Kahn se and porte djr. 1988. Islet dysfunction in noninsulin-dependent diabetes mellitus. Am j med 85 (5a): 4-8

Kibiti cm. 2006. Hypoglycaemic potential of some kenyan plants used in traditional medicine in rift valley, nairobi and eastern provinces, msc thesi


Refbacks

  • There are currently no refbacks.